Enhanced cellular uptake of maleimide-modified liposomes via thiol-mediated transport

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 2849-2861

  Li, Tianshu ^a   Takeoka, Shinji ^a  

^a WASEDA UNIVERSITY   (Japan)

Author keywords

Endocytosis; Energy independent transport; Liposome; Maleimide; Protein disulfide isomerase; Thiol reactive

Indexed keywords

1,5 DIHEXADECYL N,N DIGLUTAMYLLYSYLGLUTAMATE; CHOLESTEROL 1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; CLATHRIN; GLUTAMIC ACID; LIPOSOME; MALEIMIDE; MALEIMIDE POLY(ETHYLENE GLYCOL) 1,5 DIOACTADECYL GLUTAMATE; NANOPARTICLE; OXIDOREDUCTASE; PHOSPHOETHANOLAMINE; POLY(ETHYLENE GLYCOL) 1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; PROTEIN DISULFIDE ISOMERASE; THIOL; UNCLASSIFIED DRUG; BIOMATERIAL; MALEIMIDE DERIVATIVE; NANOCAPSULE; THIOL DERIVATIVE;

ARTICLE; CAVEOLA; CELL ASSAY; CELL MIGRATION; CELL SURFACE; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME ASSAY; INTERNALIZATION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PINOCYTOSIS; ABSORPTION; ANIMAL; CELL MEMBRANE; CHEMISTRY; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; ENDOCYTOSIS; HELA CELL LINE; HUMAN; METABOLISM; PHYSIOLOGY;

ABSORPTION, PHYSIOLOGICAL; ANIMALS; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; COATED MATERIALS, BIOCOMPATIBLE; COS CELLS; ENDOCYTOSIS; HELA CELLS; HUMANS; LIPOSOMES; MALEIMIDES; NANOCAPSULES; SULFHYDRYL COMPOUNDS;

EID: 84901979398     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S58540     Document Type: Article

References (34)

1. Cai Z, Yan LJ. Protein oxidative modifications: beneficial roles in disease and health. J Biochem Pharmacol Res. 2013;1(1):15-26.
2. Hogg PJ. Disulfide bonds as switches for protein function. Trends Biochem Sci. 2003;28(4):210-214.
3. Arnér ES, Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. 2000;267(20):6102-6109.
4. Wilkinson B, Gilbert HF. Protein disulfide isomerase. Biochim Biophys Acta. 2004;1699(1-2):35-44.
5. Arunachalam B, Phan UT, Geuze HJ, Cresswell P. Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A. 2000;97(2):745-750.
6. Saito G, Swanson JA, Lee KD. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deli Rev. 2003;55(2):199-215.
7. Aubry S, Burlina F, Dupont E, etal. Cell-surface thiols affect cell entry of disulfide-conjugated peptides. FASEB J. 2009;23(9):2956-2967.
8. Torres AG, Gait MJ. Exploiting cell surface thiols to enhance cellular uptake. Trends Biotechnol. 2012;30(4):185-190.
9. Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Release. 2010;145(3):182-195.
10. Mukherjee S, Ghosh RN, Maxfield FR. Endocytosis. Physiol Rev. 1997;77(3):759-803.
11. Schmid EM, McMahon HT. Integrating molecular and network biology to decode endocytosis. Nature. 2007;448(7156):883-888.
12. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem. 2009;78:857-902.
13. Ivanov AI. Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol Biol. 2008;440:15-33.
14. Mercer J, Helenius A. Virus entry by macropinocytosis. Nat Cell Biol. 2009;11(5):510-520.
15. Hansen SH, Olsson A, Casanova JE. Wortmannin, an inhibitor of phosphoinositide 3-kinase, inhibits transcytosis in polarized epithelial cells. J Biol Chem. 1995;270(47):28425-28432.
16. Dutta D, Donaldson JG. Search for inhibitors of endocytosis: Intended specificity and unintended consequences. Cell Logis. 2012;2(4): 203-208.
17. Li T, Takeoka S. A novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes. Int J Nanomedicine. 2013;8:3855-3866.
18. Okamura Y, Maekawa I, Teramura Y, etal. Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo. Bioconjug Chem. 2005;16(6):1589-1596.
19. Obata Y, Tajima S, Takeoka S. Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo. J Control Release. 2010;142(2): 267-276.
20. Zelphati O, Uyechi LS, Barron LG, Szoka FC Jr. Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. Biochim Biophys Acta. 1998;1390(2):119-133.
21. Johnstone SA, Masin D, Mayer L, Bally MB. Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages. Biochim Biophys Acta. 2001;1513(1):25-37.
22. Nel AE, Mädler L, Velegol D, etal. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009;8(7):543-557.
23. Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small. 2010;6(1):12-21.
24. Verma A, Uzun O, Hu Y, etal. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater. 2008;7(7):588-595.
25. Dickerhof N, Kleffmann T, Jack R, McCormick S. Bacitracin inhibits the reductive activity of protein disulfide isomerase by disulfide bond formation with free cysteines in the substrate-binding domain. FEBS J. 2011;278(12):2034-2043.
26. Mandel R, Ryser HJ, Ghani F, Wu M, Peak D. Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci U S A. 1993;90(9): 4112-4116.
27. Fenouillet E, Barbouche R, Courageot J, Miquelis R. The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell binding. J Infect Dis. 2001;183(5):744-752.
28. Jain S, McGinnes LW, Morrison TG. Thiol/disulfide exchange is required for membrane fusion directed by the Newcastle disease virus fusion protein. J Virol. 2007;81(5):2328-2339.
29. Goplen D, Wang J, Enger PØ, etal. Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Res. 2006;66(20):9895-9902.
30. Willingham MC, Rutherford AV, Gallo MG, etal. Receptor-mediated endocytosis in cultured fibroblasts: cryptic coated pits and the formation of receptosomes. J Histochem Cytochem. 1981;29(9):1003-1013.
31. Smith PJ, Giroud M, Wiggins HL, etal. Cellular entry of nanoparticles via serum sensitive clathrin-mediated endocytosis, and plasma membrane permeabilization. Int J Nanomedicine. 2012;7:2045-2055.
32. Escriou V, Ciolina C, Lacroix F, Byk G, Scherman D, Wils P. Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim Biophys Acta. 1998;1368(2):276-288.
33. Schwegler JS, Heppelmann B, Mildenberger S, Silbernagl S. Receptor-mediated endocytosis of albumin in cultured opossum kidney cells: a model for proximal tubular protein reabsorption. Pflugers Arch. 1991;418(4):383-392.
34. Brunskill NJ, Stuart J, Tobin AB, Walls J, Nahorski S. Receptor-mediated endocytosis of albumin by kidney proximal tubule cells is regulated by phosphatidylinositide 3-kinase. J Clin Invest. 1998;101(10):2140-2150.